The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 237,669 | 1,466,100 | SH | SOLE | 1,466,100 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 62,306 | 3,120,000 | SH | SOLE | 3,120,000 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 31,459 | 2,735,600 | SH | SOLE | 2,735,600 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 10,827 | 1,207,000 | SH | SOLE | 1,207,000 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 17,448 | 2,865,000 | SH | SOLE | 2,865,000 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 10,373 | 688,330 | SH | SOLE | 688,330 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 196,193 | 399,400 | SH | SOLE | 399,400 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 10,670 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 28,783 | 912,000 | SH | SOLE | 912,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 55,495 | 176,000 | SH | SOLE | 176,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 43,920 | 955,000 | SH | SOLE | 955,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 196,200 | 2,915,300 | SH | SOLE | 2,915,300 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 4,900 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 245,458 | 3,700,000 | SH | SOLE | 3,700,000 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 191,702 | 5,668,300 | SH | SOLE | 5,668,300 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 37,771 | 2,045,000 | SH | SOLE | 2,045,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 29,428 | 711,000 | SH | SOLE | 711,000 | 0 | 0 | ||
BAUSCH HEALTH COS INC | COM | 071734107 | 38,724 | 1,694,700 | SH | SOLE | 1,694,700 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 148,528 | 1,915,500 | SH | SOLE | 1,915,500 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 4,935 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 25,353 | 3,685,000 | SH | SOLE | 3,685,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 76,869 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 145,960 | 1,231,000 | SH | SOLE | 1,231,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 18,601 | 291,184 | SH | SOLE | 291,184 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 52,975 | 1,196,100 | SH | SOLE | 1,196,100 | 0 | 0 | ||
CAREMAX INC | COM CL A | 14171W103 | 5,642 | 755,329 | SH | SOLE | 755,329 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 25,879 | 2,819,067 | SH | SOLE | 2,819,067 | 0 | 0 | ||
CATALENT INC | COM | 148806102 | 86,724 | 782,000 | SH | SOLE | 782,000 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 10,890 | 865,000 | SH | SOLE | 865,000 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 29,457 | 1,175,000 | SH | SOLE | 1,175,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 2,740 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 6,975 | 1,850,000 | SH | SOLE | 1,850,000 | 0 | 0 | ||
DYNAMICS SPECIAL PURPOSE COR | CLASS A COM | 268010105 | 4,935 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 51,797 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 8,557 | 995,000 | SH | SOLE | 995,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 15,203 | 2,460,000 | SH | SOLE | 2,460,000 | 0 | 0 | ||
FIELD TRIP HEALTH LTD | COM | 31656R102 | 3,988 | 2,976,000 | SH | SOLE | 2,976,000 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 13,334 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 3,621 | 710,000 | SH | SOLE | 710,000 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 2,307 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,964 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 4,440 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 119,035 | 1,131,400 | SH | SOLE | 1,131,400 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 86,555 | 198,900 | SH | SOLE | 198,900 | 0 | 0 | ||
HYPERFINE INC | COM CL A | 44916K106 | 5,323 | 1,503,754 | SH | SOLE | 1,503,754 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 30,101 | 2,690,000 | SH | SOLE | 2,690,000 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 40,778 | 1,363,800 | SH | SOLE | 1,363,800 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 31,832 | 1,354,539 | SH | SOLE | 1,354,539 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 28,347 | 390,075 | SH | SOLE | 390,075 | 0 | 0 | ||
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 98,046 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 100,620 | 6,043,219 | SH | SOLE | 6,043,219 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 108,981 | 6,475,400 | SH | SOLE | 6,475,400 | 0 | 0 | ||
JOHNSON & JOHNSON | COM | 478160104 | 62,739 | 354,000 | SH | SOLE | 354,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 58,469 | 3,518,000 | SH | SOLE | 3,518,000 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 39,792 | 1,095,000 | SH | SOLE | 1,095,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 58,012 | 189,500 | SH | SOLE | 189,500 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 5,086 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 25 | 57,770 | SH | SOLE | 57,770 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 194,459 | 2,370,000 | SH | SOLE | 2,370,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 114,532 | 1,393,000 | SH | SOLE | 1,393,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 52,884 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 108,750 | 1,160,000 | SH | SOLE | 1,160,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 25,537 | 4,855,006 | SH | SOLE | 4,855,006 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 76 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
ONCOSEC MED INC | COM | 68234L306 | 3,387 | 2,945,000 | SH | SOLE | 2,945,000 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 3,240 | 1,349,905 | SH | SOLE | 1,349,905 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 4,875 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 23,102 | 104,000 | SH | SOLE | 104,000 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 5,815 | 4,405,000 | SH | SOLE | 4,405,000 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 26,485 | 1,946,000 | SH | SOLE | 1,946,000 | 0 | 0 | ||
SCIENCE 37 HOLDINGS INC | COM | 808644108 | 2,301 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 2,127 | 544,043 | SH | SOLE | 544,043 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 14,405 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SEASPINE HLDGS CORP | COM | 81255T108 | 24,442 | 2,010,000 | SH | SOLE | 2,010,000 | 0 | 0 | ||
SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 2,917 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
SENTINELONE INC | CL A | 81730H109 | 7,922 | 204,500 | SH | SOLE | 204,500 | 0 | 0 | ||
SI-BONE INC | COM | 825704109 | 22,600 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLD CRPI | CLASS A ORD SHS | G8253W109 | 1,980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 1,948 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253T106 | 1,978 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 1,950 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 39,547 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A900 | 296,604 | 3,300,000 | SH | Call | SOLE | 3,300,000 | 0 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 83,831 | 4,823,400 | SH | SOLE | 4,823,400 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 5,465 | 721,000 | SH | SOLE | 721,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 63,107 | 869,000 | SH | SOLE | 869,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 128,986 | 718,946 | SH | SOLE | 718,946 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 132,388 | 259,600 | SH | SOLE | 259,600 | 0 | 0 | ||
VERTEX PHARMACEUTICALS | COM | 92532F100 | 142,385 | 545,600 | SH | SOLE | 545,600 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 20,062 | 780,000 | SH | SOLE | 780,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 19,230 | 1,040,000 | SH | SOLE | 1,040,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 146,587 | 3,176,999 | SH | SOLE | 3,176,999 | 0 | 0 |